Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...

Descrición completa

Detalles Bibliográficos
Main Authors: Han, J-H, Cho, J-S, Ong, JJY, Park, J-H, Nyunt, MH, Sutanto, E, Trimarsanto, H, Petros, B, Aseffa, A, Getachew, S, Sriprawat, K, Anstey, NM, Grigg, MJ, Barber, BE, William, T, Qi, G, Liu, Y, Pearson, RD, Auburn, S, Price, RN, Nosten, F, Rénia, L, Russell, B, Han, E-T
Formato: Journal article
Idioma:English
Publicado: Public Library of Science 2020

Títulos similares